Date : October 2, 2018

New Pick:  Wayland Group Corp. (OTCMKTS: MRRCF)

Unless you’ve been living under a rock, the cannabis space is on fire right now. It is our sacred mission to find stocks that have potential upside in that space that the crowd hasn’t really found yet.

Enter MRRCF.

Shares are pulling back to test key support in this Canadian cannabis play. The company is making real money right now, with millions in revenues over the past few quarters. And that topline is growing at an astounding 82% (in other words, better than NFLX, AMZN, GOOG, FB, and APPL, by a significant margin).

Have a look at the details!

Symbol:  MRRCF

Company:  Wayland Group Corp.

Quote:  http://finance.yahoo.com/q?s=MRRCF

Latest News:  http://finance.yahoo.com/q/h?s=MRRCF+Headlines

Company Website: https://maricann.com/

Who is MRRCF

Wayland Group Corp. (CSE: WAYL); (OTC: MRRCF) – a unique marijuana company that has seen rapid expansion and diversification…yet whose shares currently trade at a fraction of the valuations of other licensed producers in the space.

And with $180 million in capital raised to date – and over $34 million cash in the bank after its’ recently completed financing of $37 million – the company is on sound financial footing and well-positioned for rapid growth.

The Rapid Rise of a $22.6 Billion
Canadian Industry

According to industry expert Deloitte, the Canadian marijuana industry could rapidly grow in size to become a CAD $22.6billion market over the coming years.ii

  •  

This “once-in-a-lifetime” legalization opportunity has sparked a wave of expansion plans among licensed producers.

For those investors looking to take advantage of the surge in value enjoyed by many Canadian marijuana companies, there have been some impressive returns, including…

  • Tilray, Inc. (TSE: TLRY) – up 202.94% over the past month and half…
    • Canopy Growth (TSE: WEED) – up 406.9% over the past 12 months….
    • Aurora Cannabis (TSE: ACB) – up 180.7% over the past 12 months…
    • The Hydropothecary (TSE: HEXO) – up 210.1% over the past 12 months…

Recent Catalysts

Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company) is pleased to announce that the Company will open its first retail location in Zurich, Switzerland in 2019 – serving the market with high quality cannabis products that contain a maximum THC content of 1 percent.

Side with hempspert

This opportunity comes on the heels of the Company’s strategic acquisition of Haxxon AG (“Haxxon”) in May 2018, granting Wayland the opportunity to leverage Haxxon’s production facilities in Regensdorf, Switzerland, and their production of feminized high CBD cannabis plants.

“Already positioned to be a meaningful leader in this category, a retail footprint in Switzerland grants us the opportunity to bring an elevated standard of product to market in Europe, while also engaging these insights and learnings as we widen our potential retail expansion to Canada,” said Ben Ward, CEO of Wayland Group Corp. “We’re committed to bringing an elevated shopping experience to the cannabis category, and we’re excited that experience will start in Zurich.”

The retail location will encompass an enhanced experience center where people will be able to sample and test different strains and devices.

Maricann Group Inc., through its subsidiaries, is operating under the Wayland Group name. For further details see the press release dated September 24, 2018.

Technical Analysis

ayland Group Corp. (OTCMKTS: MRRCF) is a vertically integrated producer and distributor of cannabis for medical purposes. The Company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal licence from the Government of Canada. The Company also has production operations in Dresden, Saxony, Germany and Regensdorf, Switzerland. Wayland is currently undertaking an expansion of its cultivation and support facilities in Canada in a 942,000 sq. ft. (87,515 sq. m) and will continue to pursue new opportunities in Europe.

Wayland Group Corp produces and sells marijuana for medical purposes. It offers dried marijuana, cannabis oil, and cannabis seeds and clones, as well as accessories, including vaporizers and other paraphernalia. The company was founded in 2013 and is headquartered in Burlington, Canada.

Wayland Group Corp is a publicly traded medical cannabis company that serves thousands of patients. Wayland Group Corp. is currently expanding its cultivation, extraction, analytics and production facilities to elevate offerings and prepare for growth into the adult-use cannabis market in Canada, and ultimately into mature and developing cannabis markets worldwide. With dedication to quality, integrity, authenticity, approachability and innovation, Wayland Group Corp. strives to exceed expectations and industry standards.

As noted above, MRRCF has a significant war chest ($6.3M) of cash on the books, which compares with about $9.9M in total current liabilities. MRRCF is pulling in trailing 12-month revenues of $2.5M. In addition, the company is seeing major top-line growth, with y/y quarterly revenues growing at 82.3%.

The company just announced that it will open its first retail location in Zurich, Switzerland in 2019 – serving the market with high quality cannabis products that contain a maximum THC content of 1 percent.

“Already positioned to be a meaningful leader in this category, a retail footprint in Switzerland grants us the opportunity to bring an elevated standard of product to market in Europe, while also engaging these insights and learnings as we widen our potential retail expansion to Canada,” said Ben Ward, CEO of Wayland Group Corp. “We’re committed to bringing an elevated shopping experience to the cannabis category, and we’re excited that experience will start in Zurich.”

The chart offers a nice pullback opportunity, with the cannabis space red hot and shares of this stock now dipping back to catch support around a rising 50-day simple moving average.

Given the extreme momentum in the space right now, and the fact that Canada is set to legalize cannabis for “adult use” in just a couple weeks, this pullback in MRRCF could offer an extremely interesting opportunity. Keep it on the radar!

About MRRCF

MRRCF (Wayland Group Corp.) is a vertically integrated producer and distributor of cannabis for medical purposes. The Company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario where it operates a medicinal cannabis cultivation, extraction, formulation and distribution business under federal licence from the Government of Canada.

The Company also has production operations in Dresden, Saxony, Germany and Regensdorf, Switzerland. Wayland is currently undertaking an expansion of its cultivation and support facilities in Canada in a 942,000 sq. ft. (87,515 sq. m) and will continue to pursue new opportunities in Europe.

Key Points:

  • MRRCF is making real money, with trailing revs already coming in at $2.5M.
  • MRRCF is starting to see major topline growth, with quarterly y/y revs increasing at 82%.
  • MRRCF is coming off an RSI trough under 50, pointing to a massively oversold stock now heading back the other way.
  • MRRCF just recorded a MACD Bullish reversal, suggesting a technical change in trend.
  • MRRCF is testing key support in an upward trending chart at the rising 50-day simple moving average.

In the race to ramp up production for licensed producers, Wayland (CSE: WAYL); (OTC: MRRCFoffers a critical “head start” of at least 3-4 years over other companies looking to enter the space, as licensing, planning and early construction have already been taken care of.

In Canada, Wayland’s (CSE: WAYL); (OTC: MRRCFLangton facility is the company’s crown jewel – a state-of-the-art facility with 217,000 square feet of grow and production space with the annual capacity to grow up to 36,000 kilograms…which is worth an estimated $180 million in annual revenue.

Subscribe To Our Daily Newsletter